Background Vasopressors are administered to critically ill patients with vasodilatory shock
not responsive to volume resuscitation, and less often in cardiogenic shock, and …

After fluid administration for vasodilatory shock, vasopressors are commonly infused.
Causes of vasodilatory shock include septic shock, post-cardiovascular surgery, post-acute …

The COVID-19 global pandemic presents with a wide range of clinical manifestations,
including biochemical, echocardiographic, and electrocardiographic (ECG) evidence of …

Methods: We selected studies in adults with septic shock that compared the outcomes of
patients treated with vasopressin versus norepinephrine. Cochrane ROB 2.0 and the …

In this issue of the Journal, Permpikul and colleagues (pp. 1097–1105) report on a phase 2
randomized controlled trial (RCT) of early low-dose norepinephrine (NE) in septic shock (1) …

Our study focused on evaluating the effect of three common vasoactive drugs on the
prognosis of elderly patients with sepsis and pre-existing heart failure. The Medical …

Background: Arginine vasopressin (AVP) is suggested as an adjunct to norepinephrine in
patients with septic shock. Guidelines recommend an AVP dosage up to 0.03 units/min, but …

Objective is the early recognition and management of sepsis. Sepsis is medical emergency,
associated with high morbidity and mortality, and early recognition and standardized …

Objectives: Guidelines recommend use of norepinephrine as the first-line treatment for fluid-
refractory septic shock and if septic shock persists vasopressin may be initiated. Since there …

Abstract Rationale Coronavirus disease 2019 (COVID‐19) is associated with many clinical
manifestations including respiratory failure and cardiovascular compromise. Objectives We …